Will Medtronic plc report Above 6% cardiovascular organic revenue growth in fiscal 2027?

If Medtronic plc reports Above 6% cardiovascular organic revenue growth in fiscal 2027, then the market resolves to Yes. This market refers to the annual figure reported in Medtronic plc's full fiscal year or Q4 earnings release. Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names are the property of their respective owners.